This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): AC-607, NG-0711
Description: AC607 is a novel biologic therapy composed of allogeneic adult bone marrow-derived mesenchymal stem cells (MSC). AC607 avoids recognition by the immune system, does not require donor matching, and is genetically stable.
AC607 is given as an intra-aortic infusion.
Additional information available to subscribers only: